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Abstract
Background: Type I collagen is an abundant natural polymer with several applications in medicine as matrix to
regenerate tissues. Silver nanoparticles is an important nanotechnology material with many utilities in some areas
such as medicine, biology and chemistry. The present study focused on the synthesis of silver nanoparticles
(AgNPs) stabilized with type I collagen (AgNPcol) to build a nanomaterial with biological utility. Three formulations
of AgNPcol were physicochemical characterized, antibacterial activity in vitro and cell viability assays were analyzed.
AgNPcol was characterized by means of the following: ultraviolet–visible spectroscopy, dynamic light scattering
analysis, Fourier transform infrared spectroscopy, atomic absorption analysis, transmission electron microscopy and
of X-ray diffraction analysis.
Results: All AgNPcol showed spherical and positive zeta potential. The AgNPcol at a molar ratio of 1:6 showed
better characteristics, smaller hydrodynamic diameter (64.34 ± 16.05) and polydispersity index (0.40 ± 0.05), and
higher absorbance and silver reduction efficiency (0.645 mM), when compared with the particles prepared in other
mixing ratios. Furthermore, these particles showed antimicrobial activity against both Staphylococcus aureus and
Escherichia coli and no toxicity to the cells at the examined concentrations.
Conclusions: The resulted particles exhibited favorable characteristics, including the spherical shape, diameter
between 64.34 nm and 81.76 nm, positive zeta potential, antibacterial activity, and non-toxicity to the tested cells
(OSCC).
Keywords: Silver nanoparticles, Collagen, Antimicrobial activity, Cell viability
Background
Collagen is the most abundant protein constituting to
the 30% of total protein and 6% of animal body weight
[1,2]. Type I collagen, a natural polymer, is a major
extracellular matrix protein in mammals and exhibits fa-
vorable characteristics for promoting cell proliferation
[3-5]. It can influence the cell physiology and mor-
phology [4,6], create a good matrix for endothelial cells
in vitro, induce platelet aggregation, promote blood clot-
ting, and consequently accelerate the healing of skin
wounds [7].
Since 1980s, some scientists have been using collagen as
a matrix to regenerate tissues for repairing skin [8], bone
[9], knee meniscal [10], joint cartilage [11], esophagus
[12], dura mater [13], muscle [14] and nervous system
[15]. The use of collagen combined with glycosaminogly-
cans as a skin implant has been already tested [16,17]. The
ability of collagen gel to regenerate cornea and nerves has
been also demonstrated by recent animal studies and cli-
nical trials [18,19]. Furthermore, it has been shown that
the combined collagen and hyaluronic acid can promote
the revascularization of tissues in animal models [20].
In the field of nanotechnology, collagen scaffold has
been widely used in biological experiments for introdu-
cing chemical and pharmaceutical substances. Bakare
et al. [21] proposed a method for constructing a film
by using poly(hydroxybutyrate valerate) (PHBV) grafted
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with scaffold tipo I collagen to support silver nanopar-
ticles (AgNPs). Jithendra et al. [22] suggested a blend of
Aloe Vera with collagen and chitosan scaffold for tissue
engineering applications.
Metal nanoparticle, especially those made of noble
metals, show excellent properties for biotechnology ap-
plications [23–25]. In particular, AgNPs have established
a broad range of applications in the majority of biome-
dical studies [26], due to their antibacterial ability and
selective toxicity to microorganisms [27].
In addition, AgNPs are widely used in various medical
and industrial fields for venous catheters coating; vas-
cular prostheses manufacturing; wound dressing manu-
facturing; treatment for chronic wounds and ulcers [25];
or as a constituent incorporated into cement for the re-
alignment of bone fractures [27], in to water purification
filter [28] and into wall paint for providing an aseptic
environment to hospital patients [29].
The ability of AgNPs to control bacterial activity relies
on the interactions with three major structural compo-
nents of the bacteria: namely peptidoglycan in the cell
wall, DNA, and proteins, by mainly affecting the en-
zymes involved in the electron transport chain [30–33].
The ideal properties of AgNPs for biomedical applica-
tions include prolonged effectiveness, high levels of bac-
tericidal and bacteriostatic activity, ability to prevent a
broad spectrum of bacteria, high biocompatibility, and
low toxicity in vivo [33]. In particular, the shape and
concentration of AgNPs in solutions are important fac-
tors in ensuring the effective contact of the particles
with the bacterial membranes and in determining the
amount of AgNPs for effectively inhibiting the targeting
bacteria [34].
Some literatures reported the application of AgNPs for
treating the wounds of mice, and these particles showed
excellent tensile properties and resulted in improved
alignment of fibers for skin repair [35,36].
Based on the previously discussed properties and
applications of collagen and AgNPs, we designed and
synthesized three types of AgNPs stabilized with type I
collagen (AgNPcols) by using a chemical synthesis route
in the present study. This article presents their chemical
synthesis, physicochemical characterization, analysis of
activity against gram-positive and gram-negative bac-
teria, and in vitro cell viability assays.
Results and discussion
Type I collagen is the most abundant protein in mammals
and is present during tissue repair [1–5,7]. Although colla-
gen has been used in biomedical research for several years,
AgNPs stabilized with collagen, as well as their biocom-
patibility and antibacterial properties, have been recently
reported by Alarcon et al. [37]. The authors used a photo-
chemical route for fabricating AgNPs from silver nitrate
(AgNO3), and this route was different from the chemical
route employed in this study, where a reducing agent, so-
dium borohydride (NaBH4), was involved. Because NaBH4
is unstable when being in contact with water at room
temperature, it is necessary to stabilize NaBH4 by using
ultra-pure water at low temperature (4°C) and keep the
solution refrigerated until use. In addition, Sun et al. [38]
reported the use of NaBH4 for the synthesis AgNPs
associated to a trisodium citrate solution. Thereafter, a
multilayer film consisting of AgNPs and collagen in a
layer-by-layer (LbL) configuration is generally constructed
for stabilizing the particles.
An exclusive study on AgNPs stabilized by collagen
has been reported [37]. Based on this study, we designed
and synthesized three different formulations of AgNPs,
at AgNO3 to NaBH4 molar ratios of 1:1, 1:6, and 1:15,
by varying the concentration of NaBH4 to obtain the
best silver (Ag0) reduction result in solution. The solu-
tion at the AgNO3/NaBH4 molar ratio of 1:6 resulted in
a final Ag0 concentration of 0.64 mM (Table 1), as con-
firmed by the atomic absorption test. In the ratio of 1:1
between AgNO3 and NaBH4, the amount of reducer was
not sufficient to reduce all molecules of silver. At ratio
of 1:6 was obtained the best concentration for the che-
mical reaction, probably the molecules amount of AgNO3
and NaBH4 reached an optimum value for reduction.
However, the ratio was 1:15 excess NaBH4 causing release
of ions in solution and forming nanoparticles with hydro-
dynamic diameter higher by aggregation [39].
All synthesized solutions were characterized in terms of
particle size, zeta potential, and polydispersity index (PDI)
by dynamic light scattering (DLS) analysis. A positive po-
tential (19.9–31.8 mV) was obtained for all AgNPcols
(Table 1). This occurs due to amino group carries a posi-
tive charge and is present in AgNPcol [40,41] (Figure 1D).
The hydrodynamic diameter of the nanoparticles was bet-
ween 64.34 nm and 81.76 nm and PDI value was between
Table 1 Diameter, zeta potential, PDI of AgNPcols (mean ± standard deviation) and molar concentration of silver in the
solution
Diameter (nm) Zeta Potential (mv) PDI* [Ag] (mM)
AgNPcol (1:1) 78.87 ± 12.89 31.8 ± 0.62 0.60 ± 0.02 0.434
AgNPcol (1:6) 64.34 ± 16.05 24.9 ± 0.79 0.10 ± 0.05 0.645
AgNPcol (1:15) 81.76 ± 18.22 19.9 ± 0.4 0.77 ± 0.17 0.345
*PDI: polydisperity index.
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0.40 and 0.77. The AgNPs associated with titanium
dioxide synthesized by Desai and Kowshik [42] showed
PDI value of 0.47, which was very close to the result ob-
tained from this study, although other PDI values were
also reported [43–45]. The value of PDI is one of the
major parameters used for selecting a low-polydispersity
solution for the subsequent cell viability test.
The presence of a positive zeta potential favors the
interaction between the particles and Gram-negative and
Gram-positive bacteria [46]. The efficiency of ionic silver
against bacteria with negatively charged membranes is
related to the electrostatic attraction caused by the posi-
tive potentials of the particles [47]. In the present study,
the positive zeta potential of AgNPcols is one of the
aspects that may explain the favorable result of its ac-
ting against E. coli and S. aureus. Hamouda and Baker
[48] reported that the opposite surface charges could
promote the interactions between the bacterial mem-
branes and AgNPs. They also mentioned that, due to the
small size of nanoparticles, the tested solutions could
easily permeate the membranes of the bacteria and pro-
mote their death [34,49]. Furthermore, Baker et al. [50]
reported that small particles with large contact areas
showed increased efficiency against bacteria, as com-
pared with the particles with large sizes. Saptarshi et al.
[51] suggests that associate protein with nanoparticle,
there are better cell absorption because the protein
favors interaction with cell membrane facilitating inter-
action to nanoparticle with bacteria and another live
cells.
The increase in the proportion of NaBH4 during par-
ticle synthesis could reduce the zeta potential of the
resulting particles. Zhang and Wu [39] reported the
same behavior of gold nanoparticles and claimed that
this was due to the aggregation of metal particles. The
AgNPcols produced in our study demonstrated similar
behaviors, as indicated by the decrease in the amount of
nanoparticles in the solution. This is because that the
aggregated Ag0 formed larger particles, resulting in a
polydisperse solution and precipitation during centri-
fugation. The relationship between the increases of the
ratio of NaBH4 in relation to the increase in diameter of
the nanoparticles is due to the release of electrons
caused by NaBH4. Because when an increase occurs in
the concentration of NaBH4 increases the number of
free electrons in the solution and decreases the zeta po-
tential favors the aggregation of silver [39].
After synthesis, all solutions were characterized by
using ultraviolet–visible (UV–vis) spectroscopy analysis,
which was efficient for detecting the sensitive AgNPs
that could display a strong absorption peak [52,53]. In
this study, we found a wider plasmon band and lower
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Figure 1 AgNPcol characterization. (A) Absorbance spectra of AgNPcols at three different NaBH4 to AgNO3 molar ratios; (B) FTIR spectra of
collagen; (C) XDR patterns of AgNPcol (1:6 molar ratio); (D) FTIR spectra of AgNPcol (1:6 molar ratio).
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absorption peak intensity for the solution at a higher
NaBH4 to AgNO3 molar ratio, as compared with the so-
lutions at lower molar ratios (Figure 1A). It is believed
that this is due to the aggregation of Ag0 molecules
[53,54], as indicated by the values of zeta potential de-
scribed above and the presence of large particles in
AgNPcol at molar ratio of 1:15. We can also notice the
presence of the plasmon band between 380 nm and
450 nm, and this is indicative of the spherical shape of
AgNPs [55], which can be further confirmed by trans-
mission electron microscopy (TEM) analysis (Figure 2).
Some researchers [35,56] reported that the spherical
shape is the optimal morphology for nanoparticles
against bacteria, as it can facilitate the interaction bet-
ween the particles and the bacterial membranes.
The difference in size AgNPcol found between the
results of Table 1 (DLS) and Figure 2 (MET) occurs
because the DLS diameter is measured in solution
(hydrodynamic diameter value). Already in the TEM, the
nanoparticle is no in solution and the result is a pro-
jected estimate of the diameter of the nanoparticle. The
hydrodynamic diameter of the nanoparticles (DLS) was
highlight, because this nanoparticle was developed for use
in a biological environment and will be in solution [57].
From the Fourier transform infrared spectra (FTIR)
of collagen and AgNPcol (1:6 molar ratio) (Figure 1B and
D), we can observe the presence of C =O (amine I at
1652.84 cm−1) and NH bands (amine II at 1571.64 cm−1)
in both samples of collagen and AgNPcol. However, the
band due to C =O (amine I at 1652.84 cm−1) in the
spectrum of AgNPcol showed a low intensity, indicating
that this group was possibly involved in the reduction and
stabilization of AgNPs. Sun et al. [38] suggested that these
changes were due to the association of collagen molecules
(i.e., amines) with AgNPs.
The phases of the samples were determined by X-ray
powder diffraction (XDR) analysis by searching against
databases. In Figure 1C, it can see the silver peaks
(ICSD: 44387-Ag0), with reflections identified. Traces of
silver oxides (ICSD: 35540-Ag2O, 27659-AgO, 15999/
59193-Ag2O3, 202218-Ag3O4) were also identified from
the sample. Silver oxides reflections can be found in
[Additional file 1]. This result is consistent with our ex-
pectation that oxidation products can be formed on the
Figure 2 Images of Silver nanoparticle stabilized with collagen. TEM images of AgNPcol at AgNO3/NaBH4 molar ratio of (A) 1:1, (B) 1:6, and
(C) 1:15 molar ratio. Histograms showing the particle size distribution of AgNPcol at molar ratio of (D) 1:1 (28.11 ± 10 nm), (E) 1:6 (15.17 ± 2.71 nm),
and (F) 1:15 (28.17 ± 9.45 nm) (scale bar = 0.1 μm).
Cardoso et al. Journal of Nanobiotechnology 2014, 12:36 Page 4 of 9
http://www.jnanobiotechnology.com/content/12/1/36
surface of pure silver. In addition, we found that the
amorphous phase of collagen affected the sample’s crys-
tallinity, resulting in its semi-crystalline state.
The activity of AgNPcols against the gram-positive
bacterium, Staphylococcus aureus (ATCC 29213), and
gram-negative bacterium, E. coli (ATCC 25922), was
tested by using an AgNO3 solution as control. Based on
the results of the atomic absorption spectrometric study,
the concentration of AgNPcols was corrected for the
antimicrobial assays. It was found that the behavior of
AgNPcol (1:6 molar ratio) for inhibiting the growth of
bacteria was comparable to that of AgNO3 (Table 2).
Thus, we may assume that the silver particle can main-
tain its antimicrobial property when being incorporated
into the collagen-stabilized nanoparticles. In Alarcon’s
study [37] about AgNPs stabilized with collagen, was
lower than that of AgNO3 used as control.
For the cell viability test, we chose only one synthe-
sized solution by analyzing the relevant characterization
data. AgNPcol at the molar ratio of 1:6 was chosen for
the test, due to its smaller particle size, lower PDI, and a
higher percentage of Ag0 than those of other samples, as
determined by atomic absorption spectroscopy. The re-
sults (Figure 3) indicated that the AgNPcol solution at
the tested concentrations did no cause significant dif-
ferences in cell viability as compared with the control
(CT). In addition, AgNO3 and collagen (Col) were also
used for comparison. It is known that collagen does not
show any cytotoxicity towards cells, as this can be evi-
denced by its abundance in animals and the human
body. Although AgNO3 solution was reported to be
toxic to cells, the AgNPcol at the approximate Ag con-
centration as that of AgNO3 did not show any toxicity
to the cells tested in this study. We attempted to use
higher concentrations of AgNPcol to evaluate its cyto-
toxicity; however, precipitation occurred in the solution
before incubation under the physiological pH and am-
bient temperature conditions.
Gurunathan et al. [58] performed the cell viability test
by using breast cancer cells (MDA-MB-23) and AgNP at
5 μg/ml, which did not exhibit cytotoxicity as compared
with the control. In addition, Prokopovich et al. [59]
synthesized the AgNPs by using NaBH4, and the pro-
duced nanoparticles were incorporated into the bone
cement, which did not show cytotoxicity to osteoblast
cells (MC 3TC) either.
The results of the present study showed that the syn-
thesized AgNPcol was effective against the tested bac-
teria and was non-toxic to the examined cells. Further
tests will be conducted to evaluate the in vivo cyto-
toxicity and healing ability of AgNPcol by using bio-
logical tissues and animal samples.
Conclusion
In the present study, we demonstrated the synthesis of
an AgNP solution stabilized with type I collagen by
using NaBH4 as a reducing agent. The resulted particles
exhibited favorable characteristics, including the sphe-
rical shape, diameter between 64.34 nm and 81.76 nm,
positive zeta potential, antibacterial activity, and non-
toxicity to the tested cells (OSCC). It is found that the ac-
tivity against bacterium is facilitated by the electrostatic
interaction between the positively charged AgNPcols and
the negatively charged bacterial membranes. Probably the
shape, size and positive zeta potential of AgNPcols facili-
tates the activity against gram negative bacterium and
gram positive bacterium. Furthermore, the cell viability
test provides the basics for the future study that aims to
investigate the in vivo behaviors of AgNPcols by using bio-
logical tissues.
Methods
Synthesis of collagen-based silver nanoparticles
(AgNPcols)
A solution of silver nitrate (AgNO3) at a concentration of
108 μgAg/mL, a collagen type I from rat tail (Santa Cruz
Biotechnology) solution at a concentration of 0.1 mg/ml
and a solution of borohydride (NaBH4) at 3.78 mg/ml,
prepared using ultrapure water at 4°C were used to carry
out the synthesis of nanoparticles.
The AgNO3 solution was added to the collagen, both
with the same volume and remained under agitation to
homogenize for 10 min. The NaBH4 solution was added
later, in the form of jet, for any solution of NaBH4, came
in contact with the Beker solutions quickly and com-
pletely. This solution was stirred for 10 minutes to
homogenize. Subsequently, the reaction mixture was
centrifuged at 3600 rpm for 15 minutes and finally
Table 2 Minimum inhibitory concentrations (MICs) of AgNPcol (μg Ag/mL), AgNO3 (μg Ag/mL), and standard antibiotics
(μg/mL) for inhibiting Staphylococcus aureus and Escherichia coli
AgNPcol (μgAg/mL) Controls
Bacterial strains 1:1 1:6 1:15 AgNO3 (μgAg/mL) Antibiotic (μg/mL)
S. aureus 11.7 17.4 11.7 13.5 <0.5a
E. coli 11.7 8.7 11.7 6.75 <0.5b
aOxacilin.
bMeropenen.
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separated from the supernatants of the final solution
present in the container. In the present study three
different proportions of borohydride solution regarding
Silver Nitrate (AgNO3) (molar ratio: 1:1, 1:6 e 1:15) were
selected.
Physicochemical characterization of AgNPcols
The AgNPcols were characterized by UV–vis spectros-
copy using a Shimadzu (UV 1800) spectrophotometer.
Were subsequently characterized according to their size,
electrical potential and PDI using the DLS (Malvern
Zetasizer Nano ZS Model 3600) with laser with a wave-
length of 633 nm and scattering angle of 90° all mea-
surements were performed in triplicate. To verify the
shape and confirm the diameter of the nanoparticles
non-diluted samples were placed on two screens (20 μL)
for transmission electron microscopy (TEM) previously
coated with Formvar. After drying for 2 h at room
temperature (25 ± 2°C) screens were analyzed in a Jeol
JEM-1010 electron microscope and photomicrographed
by an UltraScan® with Digital Micrograph 3.6.5 software
(Gatan/USA) [25].
In order to quantify the percentage of silver in solution,
the atomic absorption spectroscopy (Varian - Model
AA240FS) was used, with a wavelength of 328.1 nm and
multielement lamp (Varian No. 5610108700). The reading
was held in atomic absorption flame with Oxygen and
Acetylene gases.
XRD data were obtained at the Laboratory of X-ray
Crystallography of IFSC/USP using a Rigaku Rotaflex
diffractometer equipped with graphite monochromator
and rotating anode tube, operating with Cu Ka, 50 kV
and 100 mA. Powder diffraction patterns were obtained
in step scanning mode, 2θ = 5–100°, step of 0.02° and
5 s/step. Peak Fitting Module program [60] was used for
the peak decomposition of the semicrystalline pattern
and determination of area due to the amorphous phase.
Evaluation of antibacterial activity of AgNPcols
To study the antibacterial properties of AgNPcols, by the
determination of Minimum Inhibitory Concentration
(MIC), two bacterial strains were selected: Staphylococcus
aureus ATCC 29213 (Gram-positive) and Escherichia coli
ATCC 25922 (Gram-negative). The microorganisms
were cultured in Mueller-Hinton agar at 37°C for
24 hours in aerobic conditions. Then a suspension of
bacterial strains with an optical density of McFarland of
0.5 (1 × 108 CFU/mL) was made in an isotonic sodium
chloride 0.85% solution. Later in time, this solution was
diluted ten times (1 × 107 CFU/mL) and used as inoculum
in the experiment. MIC was determined according to pro-
tocols previously described [61–63] using 96-well microdi-
lution plate with Mueller-Hinton broth where the strains
(concentration of 5 × 105 CFU/mL) were exposed to two-
fold dilution series of the AgNPcols with concentrations
ranging from 34,8 to 0,36 μgAg/mL. The same procedure
was used to determine the MIC of the following controls:
collagen, AgNO3, and standard antibiotics effective against
the tested bacterial strains with concentrations ranging
from 27 to 0.42 μgAg/mL for AgNO3; 50 to 3,12 μg/mL
for collagen and 32 to 0.5 μg/mL for antibiotics. Sterile
Mueller-Hinton broth was used as the negative control
and inoculated broth was used as the positive control.
MIC was defined as the lowest concentration of agent that
restricted the visual bacterial growth in the culture media.
Cell viability
For the study of cell viability, the AgNPcol 1:6 was diluted
four times with the ratio of two, starting at a concentration
of 4.35 μgAg/ml. The cell lines used in this study was
oral squamous cell carcinoma (OSCC) obtained from
American Type Culture Collection (ATCC, Manassas,
VA). Cells were grown in 75 cm2 flasks and maintained in
Dulbecco’s modified Eagle medium (DMEM) supplemen-
ted with 10% fetal bovine serum, streptomycin/penicillin
antibiotics and non-essential aminoacids. For the experi-
ment the cells were seeded in a 96-well plate (5,000 cel./
Well) and kept in an incubator (atmosphere at 37°C and
humidified 5% CO2) for 24 hours. In a 96-well plate was
added 5 different concentrations AgNPcol solutions and
control solutions (medium, collagen - 6.25 μg/ml, AgNO3 -
3.37 μgAg/ml and AgNO3 - 6.75 μgAg/ml). The plates
Figure 3 Cell viability. Results of cell viability test of AgNPcol and
control solutions (Col and AgNO3). All data were expressed as mean ±
SEM values of three independent experiments. A value of *p < 0.05
was considered statistically significance.
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were kept in an incubator for 3 hours. Subsequently, the
added solutions were removed and placed in Hank's buffer
for 5 minutes. The buffer was removed and fresh medium
was added. After 24 hours the medium was removed
and added to a solution of DMEM without phenol and
MTT ([3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazo-
lium bromide) (15%) to each well. The plates were incu-
bated for 4 hours. Thereafter all the medium with MTT
was removed with care to do not remove formazam pro-
duced by living cells. Finally, isopropanol was added to
each well to solubilize the formazam and taken to review
the reader Safire (TECAN EUA Inc., Durham, NC). Sta-
tistical analysis was performed using Prism 5.0 (GraphPad
Software) by ANOVA and Tukey test. All data were
expressed as mean and standard deviation of three inde-
pendent experiments. We used the statistical significance
of p <0.05 for this study [64].
Additional file
Additional file 1: Additional information about XRD result.
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